Table 1.
Univariate end multivariate analysis of inhouse mortality of 521 SAB patients
| Parameter/Risk factor | Inhouse deaths (113 of 521 patients, 21.7%) |
|||
|---|---|---|---|---|
| Univariate analysis |
Multivariate analysis |
|||
| Number (%) | p value | OR (95% CI) | p value | |
| MSSA vs. MRSA | ||||
| MSSA | 85/454 (18.7%) | <0.01 | 2.7 (1.4–5.0) | <0.01 |
| MRSA | 28/67 (41.8%) | |||
| Mode of acquisition | ||||
| community-acquired | 25/109 (22.9%) | |||
| healthcare-associated | 31/147 (21.1%) | |||
| nosocomial | 57/265 (21.5%) | 0.93 | NI | |
| Age | ||||
| <60 years | 28/204 (13.7%) | |||
| ≥60 years | 85/317 (26.8%) | <0.01 | 2.4 (1.4–4.2) | <0.01 |
| Source | ||||
| unknown or catheter-related | 74/364 (20.3%) | |||
| others | 39/157 (24.8%) | 0.25 | NI | |
| Metastatic infection | ||||
| no | 69/332 (20.8%) | |||
| yes | 44/189 (23.3%) | 0.51 | NI | |
| ID consultation | ||||
| no | 47/171 (27.5%) | |||
| yes | 66/350 (18.9%) | 0.03 | 0.6 (0.4–1.0) | 0.05 |
| Endocarditis | ||||
| no | 91/465 (19.6%) | |||
| yes | 22/56 (39.3%) | <0.01 | 2.9 (1.4–5.8) | <0.01 |
| Comorbidity | ||||
| McCabe non-fatal | 25/239 (10.5%) | |||
| McCabe ultimately fatal | 77/258 (29.8%)a | <0.01 | 4.0 (2.3–6.9)a | |
| McCabe rapidly fatal | 11/24 (45.8%)a | 7.9 (2.9–21.7)a | <0.01 | |
| Initial ICU admission | ||||
| no | 40/335 (11.9%) | |||
| yes | 73/186 (39.2%) | <0.01 | 5.9 (3.6–9.7) | <0.01 |
OR, odds ratio; CI, confidence interval. NI, not included in final regression model.
a
Compared to McCabe non-fatal.